CXCL8 and rheumatoid arthritis: Indeed, APC has previously been shown to inhibit migration of lymphocytes towards IL‐8, RANTES and MCP‐1 33 and to limit migration and activation of rheumatoid arthritis monocytes via the endothelial protein C receptor (EPCR) 37.